Cargando…
CDK11(p58) inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling
BACKGROUND: CDK11(p58), a Ser/Thr kinase that belongs to the cell division cycle 2-like 1 (CDC2L1) subfamily, is associated with cell cycle progression, tumorigenesis and apoptotic signaling. CDK11(p58) is also involved in the regulation of steroid receptors, such as androgen and estrogen receptors....
Autores principales: | Chi, Yayun, Huang, Sheng, Wang, Lei, Zhou, Ruoji, Wang, Lisha, Xiao, Xiuying, Li, Dali, Cai, Ying, Zhou, Xiaoyan, Wu, Jiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138392/ https://www.ncbi.nlm.nih.gov/pubmed/25106495 http://dx.doi.org/10.1186/1471-2407-14-577 |
Ejemplares similares
-
Abnormal expression of CDK11(p58) in prostate cancer
por: Chi, Yayun, et al.
Publicado: (2014) -
Critical role of CDK11(p58) in human breast cancer growth and angiogenesis
por: Chi, Yayun, et al.
Publicado: (2015) -
ERα suppresses slug expression directly by transcriptional repression
por: Ye, Yin, et al.
Publicado: (2008) -
Progression of Mouse Skin Carcinogenesis Is Associated with Increased Erα Levels and Is Repressed by a Dominant Negative Form of Erα
por: Logotheti, Stella, et al.
Publicado: (2012) -
YAP inhibits ERα and ER(+) breast cancer growth by disrupting a TEAD-ERα signaling axis
por: Li, Xu, et al.
Publicado: (2022)